Atlas Trials

Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers

Clinical trial NCT04969497 · COMPLETED

Trial details

NCT number
NCT04969497
Sponsor
Zosano Pharma Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Migraine
Start date
2021-06-24
Primary completion
2021-09-02
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.